Pomerantz Law Firm Warns Investors in Semler Scientific, Inc. About Class Action Lawsuit Details
In a recent announcement by the Pomerantz Law Firm, investors who have incurred losses from their investments in Semler Scientific, Inc. (NASDAQ: SMLR) are being urged to pay attention to a newly filed class action lawsuit. The firm is calling for affected investors to make themselves known and consider joining the lawsuit. Those interested can reach out to Danielle Peyton at Pomerantz LLP by emailing [email protected], or by phone at 646-581-9980. This class action lawsuit centers around allegations of securities fraud and possible unlawful business practices carried out by Semler and some of its top executives.
Investors should be particularly mindful of the pressing deadlines related to this lawsuit. If you have purchased or acquired Semler securities during the specified Class Period, you have until October 28, 2025, to request the court to appoint you as the Lead Plaintiff in this litigation.
The recent troubles for Semler Scientific began when they disclosed in their 2024 annual report issued on February 28, 2025, that the U.S. Department of Justice (DOJ) might take legal action against them involving the company's QuantaFlo device. It is stated that the DOJ might file a complaint under the civil False Claims Act due to dubious claims for reimbursements that Semler made regarding the use of their device. The company previously received a civil investigative demand from the DOJ back in July 2017 concerning the same allegations. Semler admitted they participated in discussions with the DOJ regarding a settlement that did not yield a positive outcome in February.
The impact of this news was reflected in the stock market the following day, with Semler's shares dropping significantly by $4.03, representing a 9.4% decline that brought the closing price to $38.89 per share on March 3, 2025. Following further developments, including the announcement on April 15, 2025, that Semler reached a tentative agreement with the DOJ for a $29.75 million settlement concerning outstanding claims, the stock experienced yet another decline, falling $3.40 or 9.88%, to close at $31.00 per share the next day.
Pomerantz LLP, known as a leading firm specializing in corporate, securities, and antitrust class action lawsuits, continues to advocate for investors who have been wronged. Founded over 85 years ago by Abraham L. Pomerantz, the firm is recognized for setting the standard for class action litigations, particularly in the realm of securities fraud. They have successfully recovered substantial damages on behalf of numerous clients impacted by corporate misconduct.
If you've been financially impacted by Semler Scientific's fluctuating stock due to potential securities fraud, it is crucial to act promptly. Time is of the essence, and Pomerantz LLP encourages affected investors to connect and explore their legal options before the deadline of October 28, 2025. For further details, interested individuals can obtain a copy of the complaint filed by visiting www.pomerantzlaw.com. Investor rights and protections are at the forefront of this class action, and joining can help amplify the voices of those wronged by corporate actions.
Investors should be particularly mindful of the pressing deadlines related to this lawsuit. If you have purchased or acquired Semler securities during the specified Class Period, you have until October 28, 2025, to request the court to appoint you as the Lead Plaintiff in this litigation.
The recent troubles for Semler Scientific began when they disclosed in their 2024 annual report issued on February 28, 2025, that the U.S. Department of Justice (DOJ) might take legal action against them involving the company's QuantaFlo device. It is stated that the DOJ might file a complaint under the civil False Claims Act due to dubious claims for reimbursements that Semler made regarding the use of their device. The company previously received a civil investigative demand from the DOJ back in July 2017 concerning the same allegations. Semler admitted they participated in discussions with the DOJ regarding a settlement that did not yield a positive outcome in February.
The impact of this news was reflected in the stock market the following day, with Semler's shares dropping significantly by $4.03, representing a 9.4% decline that brought the closing price to $38.89 per share on March 3, 2025. Following further developments, including the announcement on April 15, 2025, that Semler reached a tentative agreement with the DOJ for a $29.75 million settlement concerning outstanding claims, the stock experienced yet another decline, falling $3.40 or 9.88%, to close at $31.00 per share the next day.
Pomerantz LLP, known as a leading firm specializing in corporate, securities, and antitrust class action lawsuits, continues to advocate for investors who have been wronged. Founded over 85 years ago by Abraham L. Pomerantz, the firm is recognized for setting the standard for class action litigations, particularly in the realm of securities fraud. They have successfully recovered substantial damages on behalf of numerous clients impacted by corporate misconduct.
If you've been financially impacted by Semler Scientific's fluctuating stock due to potential securities fraud, it is crucial to act promptly. Time is of the essence, and Pomerantz LLP encourages affected investors to connect and explore their legal options before the deadline of October 28, 2025. For further details, interested individuals can obtain a copy of the complaint filed by visiting www.pomerantzlaw.com. Investor rights and protections are at the forefront of this class action, and joining can help amplify the voices of those wronged by corporate actions.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.